Chemoinformaics analysis of 1,4,7,10,13,16,19-HEPTAOXA-2-CYCLOHENEICOSANONE
| Molecular Weight | 322.354 | nRot | 0 |
| Heavy Atom Molecular Weight | 296.146 | nRig | 22 |
| Exact Molecular Weight | 322.163 | nRing | 1 |
| Solubility: LogS | -0.012 | nHRing | 1 |
| Solubility: LogP | -0.546 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
| nHA | 8 | APOL | 47.1326 |
| nHD | 0 | BPOL | 39.1034 |
| QED | 0.56 |
| Synth | 3.041 |
| Natural Product Likeliness | -0.103 |
| NR-PPAR-gamma | 0.025 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.885 |
| MDCK | 0.0000199 |
| BBB | 0.04 |
| PPB | 0.15296 |
| VDSS | 0.414 |
| FU | 0.413682 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.088 |
| CYP2c19-inh | 0.015 |
| CYP2c19-sub | 0.057 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.002 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.027 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.139 |
| CL | 2.561 |
| T12 | 0.734 |
| hERG | 0.993 |
| Ames | 0.065 |
| ROA | 0.007 |
| SkinSen | 0.903 |
| Carcinogencity | 0.23 |
| EI | 0.991 |
| Respiratory | 0.007 |
| NR-Aromatase | 0.733 |
| Antiviral | Yes |
| Prediction | 0.74793 |